CO7 Patient Reported Outcome Measure for Giant Cell Arteritis: Cross-Sectional Validation Study

Value in Health(2022)

Cited 0|Views11
No score
Abstract
Giant cell arteritis (GCA) presents in people over the age of 50 with cranial, ocular, and large vessel vasculitis. This study aims to validate a disease-specific patient reported outcome (PRO) measure for patients with GCA, to capture the impact of GCA and its treatment on health-related quality of life.
More
Translated text
Key words
giant cell arteritis,co7 patient,cross-sectional
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined